おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Adlai Nortye
company
About
Adlai Nortye is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $53M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Adlai Nortye is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with its R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, it has built a global pipeline through collaborations and internal discoveries with more than 10 drug candidates in development.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$53M
Adlai Nortye has raised a total of
$53M
in funding over 2 rounds. Their latest funding was raised on
Jun 26, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 26, 2018 | Series B | $53M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Adlai Nortye is funded by 1 investors.
Yahui Precision Medicine Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Yahui Precision Medicine Fund
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
